Skip to main content

College of Human Medicine

Supratik Rayamajhi Recommended as Interim Dean of College of Human Medicine

October 1, 2025

 Supratik-headshot.jpg

Supratik Rayamajhi, MD, FACP, will be recommended to the Michigan State University Board of Trustees to serve as the interim dean of MSU College of Human Medicine, effective Oct 1, 2025. Pending board approval, he will succeed Aron Sousa, MD, FACP, who served as dean and interim dean for seven of the past ten years.

Rayamajhi currently serves as associate dean for clinical affairs and professor of medicine, where he works with administrators, hospital leaders and clinical practices across the state to improve the financial sustainability of medical education. 

“It’s an absolute honor to serve our college in my new role,” said Rayamajhi. “Emblematic to the land grant mission of this university, the College of Human Medicine is a truly remarkable state-wide campus that touches the lives of most people within Michigan.” 

This is Rayamajhi’s second leadership role during times of change. In 2021, he was appointed interim chair of the Department of Medicine, a role he served for two and a half years.  

In his 15 years at Michigan State University, Rayamajhi has also served several other roles in the College of Human Medicine including clerkship director, program director and vice chair for education within MSU Internal Medicine Residency, and senior vice chair of clinical strategy in the Department of Medicine. 

supratik_aron_15.jpg“Dr. Rayamajhi has the attributes of a dean and leader – he lives the mission, and, in my experience, he always works to make a situation better,” said Sousa, who has been named president and chief executive officer of Rosalind Franklin University of Medicine and Sciences. “The college is in good hands.”

Rayamajhi received his medical degree from Tribhuvan University, Nepal, and graduated from the Michigan State University Internal Medicine Residency Program. He is a board-certified internist specializing in clinical hypertension. Rayamajhi is a coinvestigator on several federal grants with a focus on hypertension ranging from epigenomics to chronotherapy. He is the lead author of a book on cancer-associated thrombosis and has authored multiple peer-reviewed publications.  

Rayamajhi is a recipient of the College of Human Medicine's Outstanding Faculty Award and Michigan Chapter of the American College of Physicians Raymond Murray Governor’s Award.